Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
MEDNAX (MD) in Focus: Stock Moves 13.4% Higher
MEDNAX, Inc. (MD - Free Report) was a big mover last session, as the company saw its shares rise over 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $41.35 –$46.32 in the past one-month time frame, witnessed a sharp increase yesterday.
The company's shares rose after Elliott Management, a big hedge fund, revealed a 7% stake in the company and said that it seeks to enhance shareholders’ value.
The company has seen two positive versus three negative estimate revisions over the past one month, and the Zacks Consensus Estimate for the current quarter has also moved downward, suggesting some trouble down the road. So make sure to keep a close watch on this firm in the near future to see if this recent move higher can last.
MEDNAX currently has a Zacks Rank #3 (Hold) while its Earnings ESPis 0.00%.
Mednax, Inc Price and Consensus
Mednax, Inc Price and Consensus | Mednax, Inc Quote
A better-ranked stock in the Medical sector is Centene Corp (CNC - Free Report) , which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Is MD going up? Or down? Predict to see what others think: Up or Down
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>